Drawing for VEDA TRIALS

USPTO serial 98091041

VEDA TRIALS

Reviewed by CopyMark Law Group

Reg. 8413613Status 700Registered
Filing date
Status date
Registration date
Aug 25, 2026
Examiner
OSBORNE, AUDRIANA R
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VEDA TRIALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

ELIZABETH OLINER

ELIZABETH OLINER CRANDON LAW345 GROVE STREET, 2ND FLOORSAN FRANCISCO, CA 94102United States

Goods and services

ClassDescriptionStatusFirst use
042Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Platform as a service (PAAS) featuring computer software platforms for use in running, managing and analyzing clinical trials, namely, enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for use in managing and participating in clinical research and view data analytics, enabling site data capture, selecting configurable data collection methods with configurable options and configuring a participant-facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring non-downloadable software for use in clinical research analytics, data capture forms, electronic clinical outcome assessments (eCOA), recruitment, and electronic consent; Providing a website featuring non-downloadable software for enabling users to manage and participate in clinical research, view data analytics, enable site data capture, and screen participants for eligibility; Providing information in the field of clinical research via a website; Providing scientific research information in the field of clinical trials; none of the foregoing comprised of or consisting of the provision of healthcare or telehealth services, scheduling healthcare or telehealth appointments, or allowing a patient to access personal healthcare information for the provision of healthcare or telehealth servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 25, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 25, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 6, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 6, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 8, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 7, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 18, 2026IUAFUSE AMENDMENT FILED—
Feb 18, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 30, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 30, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 13, 2025TMBNTTAB RELEASE CASE TO TRADEMARKS—
Nov 13, 2025OP.TOPPOSITION TERMINATED NO. 999999—
Nov 13, 2025OP.DOPPOSITION DISMISSED NO. 999999—
Jul 3, 2025OP.IOPPOSITION INSTITUTED NO. 999999—
Jul 2, 2025TTBNCASE ASSIGNED TO TTAB—
Jul 2, 2025IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 2, 2025OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Jul 1, 2025PCGRPETITION TO DIRECTOR GRANTED—
Jul 1, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 27, 2025ERTITEAS RESPONSE TO PETITION INQUIRY LETTER—
Jun 10, 2025PILMPETITION INQUIRY LETTER ISSUED—
May 22, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 20, 2025APETASSIGNED TO PETITION STAFF—
May 12, 2025PCRCPETITION TO DIRECTOR RECEIVED—
Dec 12, 2024ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 13, 2024LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Nov 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 30, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 30, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Sep 30, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 30, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 30, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 30, 2024LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
Jun 28, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 28, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2024LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
May 24, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2024DOCKASSIGNED TO EXAMINER—
Aug 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 21, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance